Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study

被引：0
|
作者：
Reich, Kristian [1 ]
Silverberg, Jonathan I. [2 ]
de Bruin-Weller, Marjolein [3 ]
Deleuran, Mette [4 ]
Beck, Lisa A. [5 ]
Papp, Kim [6 ]
Farooqui, Saleem A. [7 ]
Zhang, Fan [8 ]
Feeney, Claire [9 ]
Koppensteiner, Herwig [10 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Aarhus Univ Hosp, Aarhus, Denmark
[5] Univ Rochester, Med Ctr, Rochester, NY USA
[6] Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[7] Pfizer R&D UK Ltd, Sandwich, Kent, England
[8] Pfizer Inc, Groton, CT USA
[9] Pfizer Ltd, Tadworth, Surrey, England
[10] Pfizer Corp Austria GmbH, Vienna, Austria
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
44042
引用
收藏
页码：AB116 / AB116
页数：1
相关论文
共 50 条
  • [31] Long-Term Improvement in Patients with moderate to severe atopic Dermatitis treated with Tralokinumab: An ECZTEND Interim Analysis
    Beissert, Stefan
    Blauvelt, Andrew
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Herranz, Pedro
    Pink, Andrew
    Peris, Ketty
    Fangel, Stine
    Saeki, Hidehisa
    Wollenberg, Andreas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 29 - 30
  • [32] DUPILUMAB PROVIDES LONG-TERM EFFICACY FOR UP TO 4 YEARS IN AN OPEN-LABEL EXTENSION STUDY OF ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Deleuran, Mette
    Blauvelt, Andrew
    Thyssen, Jacob P.
    Lockshin, Benjamin
    Galus, Ryszard
    Lynde, Charles
    Xiao, Jing
    Levit, Noah A.
    Rodriguez Marco, Ainara
    Shabbir, Arsalan
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 34 - 34
  • [33] Long-term efficacy of abrocitinib after initial successful treatment in patients with atopic dermatitis
    Cork, Michael J.
    Papp, Kim A.
    Deleuran, Mette
    Pink, Andrew E.
    Reich, Kristian
    Biswas, Pinaki
    Chan, Gary
    Feeney, Claire
    Chiu, Wing Sin
    Randall, Rowena M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 72 - 72
  • [34] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    ALLERGY, 2019, 74 : 182 - 182
  • [35] Dupilumab provides long-term efficacy over 2.5 years in adults with moderate-to-severe atopic dermatitis
    Cork, Michael
    Beck, Lisa
    Bissonnette, Robert
    Wollenberg, Andreas
    Simpson, Eric
    Praestgaard, Amy
    Aamodt, Kimberly
    Rossi, Ana
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 69 - 69
  • [36] LONG-TERM SAFETY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH DUPILUMAB UP TO 4 YEARS
    Blauvelt, A.
    Eichenfield, L.
    Sierka, D.
    Chen, Z.
    Khokhar, F.
    Marco, A. Rodriguez
    Shabbir, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S19 - S19
  • [37] Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
    Blauvelt, Andrew
    Langley, Richard G.
    Lacour, Jean-Philippe
    Toth, Darryl
    Laquer, Vivian
    Beissert, Stefan
    Wollenberg, Andreas
    Herranz, Pedro
    Pink, Andrew E.
    Peris, Ketty
    Fangel, Stine
    Gjerum, Le
    Corriveau, Joshua
    Saeki, Hidehisa
    Warren, Richard B.
    Simpson, Eric
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) : 815 - 824
  • [38] Long-term tralokinumab therapy in moderate to severe atopic dermatitis
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (03) : 91 - 91
  • [39] Short- and long-term cost-effectiveness of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis in China
    Shi, Yin
    Zhou, Yanwu
    Li, Shuishi
    Guan, Haijing
    Liu, Shao
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1180 - 1189
  • [40] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
12345